Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Oct 14, 2021 9:58am
168 Views
Post# 34004738

RE:RE:RE:RE:RE:RE:BNN or not to BNN?

RE:RE:RE:RE:RE:RE:BNN or not to BNN?aaaccchhhhh,,its very possible this covid trial flops as well...I hold little optimism..this team has no idea what the MOA of their drug is with the virus. A third party told them they could see a use for 208 around C19,,,,,,but not our group of misfits. Pinoccio continuing to lead us in presenting this science to the investing world has failed time and time again. What is not to understand. I see this company being taken out by insiders or in tandem with a third party at precious little market cap. The next PP/Financing for BoM2, if it ever happens, will crush existing shareholders dreams. I am hoping we get taken out for at least the worth of tax loss sometime in the coming years. I feel I have to go back to work with the losses I have incurred from this divestment cuz of share price and warrants expirying worthless. But life moves on and I am actually an optimist with realistic views. Overall,,,,RVX will contune to be a joke on the TSX around the biotech world with investors! Watch and see how this plays out with the disrespect to long time existing shareholders. 
<< Previous
Bullboard Posts
Next >>